Tailoring individualized treatment plans for acne

Cutis

Volumn 81, Issue 1 SUPPL., 2008, Pages 23-25

  Harper, Julie C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIINFECTIVE AGENT; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE;

ACNE VULGARIS; ADULT; ARTICLE; CASE REPORT; DRUG COMBINATION; DRUG CONTRAINDICATION; DRUG INTERACTION; FEMALE; HUMAN; PATIENT EDUCATION;

ACNE VULGARIS; ADULT; ALDOSTERONE ANTAGONISTS; ANTI-BACTERIAL AGENTS; CONTRACEPTIVES, ORAL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; PATIENT EDUCATION AS TOPIC; SPIRONOLACTONE;

EID: 39049130769     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2006;1:CD003987.
2. ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107: 1453-1472.
3. London BM, Lookingbill DP. Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives. Arch Dermatol. 1994;130:392-393.
4. Yaz [package insert]. Wayne, NJ: Bayer HealthCare Pharmaceuticals; 2007.